molecular science

Caris Life Sciences and ConcertAI Announce New Clinico-Genomic Research Platform

by | Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE
Caris Life Sciences
Caris Life Sciences Launches AI-Driven Profiling Tool for Tumors
by | Dec 12, 2019
The Genomic Profiling Similarity Score uses over 6,500 mathematical models in a machine learning algorithm to compare molecular characteristics of a patient's tumor against Caris' extensive database.
MORE
Follow the money concept [Illustration: Sergey Khakimullin/istockphoto]
Follow the Money: Caris Raises $150M, Meritize Gets $13.2M, iDonate Secures $10M, BenefitMall Buys Phoenix Firm
by | Oct 4, 2018
From Dallas investor Carl Sparks and 7-Eleven Ventures to Conversable and Hospice Source, here are notable funding and acquisition deals with North Texas ties.
MORE